Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesPre-MDCDRG 005-liver-transplant-with-mcc-or-intestinal-transplant
    Ask Trek AI about this page

    Liver Transplant with MCC or Intestinal Transplant: Inpatient Reimbursement Overview

    DRG 005 captures liver transplant admissions with Major Complication or Comorbidity or intestinal transplant, encompassing high-acuity surgical care and complex postoperative management. This Diagnosis-Related Group matters for inpatient reimbursement because it represents a high-cost service line where documented severity affects Medicare payment.

    Customize your policy alerts

    Sign up for drg 005 policy alerts

    Get alerted when payer policies referencing 005 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 005 Overview

    DRG 005 covers hospital admissions for liver transplant procedures with Major Complication or Comorbidity or intestinal transplant. These cases involve complex surgical intervention and intensive perioperative care, often with multisystem management needs. This Diagnosis-Related Group is a high-resource category and therefore has significant implications for Medicare payment allocations to hospitals. Accurate coding and documentation of complications or comorbidities directly affect reimbursement under this Diagnosis-Related Group.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative immunosuppression optimization trials: randomized or adaptive studies testing different immunosuppressive regimens, dosing strategies, or timing around liver transplant (including combined liver–intestinal transplants) to reduce early graft rejection and infection. These trials enroll adult and pediatric transplant recipients during the index hospitalization or immediately post‑op, comparing standard multi‑drug protocols versus modified induction or maintenance approaches with close monitoring of rejection episodes and infectious complications. Results are relevant to providers for tailoring in‑hospital management and to payers because optimized regimens can reduce ICU stays, reoperations, readmissions, and high‑cost complications that drive DRG costs.
    • Organ preservation and donor management studies: prospective trials evaluating novel organ preservation techniques, machine perfusion parameters, or donor optimization protocols to improve graft viability for marginal livers and intestinal grafts. These studies typically involve deceased‑donor organs and recipients listed for high‑risk transplant, assessing outcomes such as primary graft nonfunction, ischemia‑reperfusion injury, and need for re‑transplantation within 30–90 days. For hospitals and payers, better preservation can increase usable organ yield, lower perioperative morbidity, shorten lengths of stay, and reduce expensive salvage therapies under this DRG.
    • Post‑discharge outcomes and care‑coordination studies: cohort or pragmatic trials of structured transitional care, surveillance protocols, and outpatient multidisciplinary management to prevent late complications such as chronic rejection, biliary or anastomotic complications, and hospital readmissions. These studies follow liver and intestinal transplant recipients after the index DRG episode, often targeting high‑risk subgroups (e.g., patients with multi‑organ failure pre‑transplant or those with socioeconomic barriers), and measure readmission rates, long‑term graft survival, quality of life, and cumulative cost of care. Findings inform providers on effective post‑acute pathways and help payers identify interventions that reduce downstream utilization and total cost associated with this DRG.

    Related Codes

    001-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITH-MCC

    Heart Transplant or Implant of Heart Assist System with MCC: Inpatient Reimbursement Overview

    002-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITHOUT-MCC

    Heart Transplant or Implant of Heart Assist System without MCC: Inpatient Reimbursement Overview

    003-ECMO-OR-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITH-MAJOR-O-R-PROCEDURES

    ECMO or Tracheostomy with MV >96 Hours: Inpatient Reimbursement Overview

    004-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITHOUT-MAJOR-O-R-PROCEDURES

    Tracheostomy with Mechanical Ventilation >96 Hours: Inpatient Reimbursement Overview

    006-LIVER-TRANSPLANT-WITHOUT-MCC

    Liver Transplant without Major Complication or Comorbidity: Inpatient Reimbursement Overview

    007-LUNG-TRANSPLANT

    Lung Transplant: Inpatient Reimbursement Overview

    008-SIMULTANEOUS-PANCREAS-AND-KIDNEY-TRANSPLANT

    Simultaneous Pancreas and Kidney Transplant: Inpatient Reimbursement Overview

    010-PANCREAS-TRANSPLANT

    Pancreas Transplant: Inpatient Reimbursement Overview

    011-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-MCC

    Tracheostomy/Laryngectomy with MCC: Inpatient Reimbursement Overview

    012-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-CC

    Tracheostomy and Laryngectomy with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 16

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.